Document is current
Any future updates will be listed below
-
Authors
Takagi, Shunichi
Suzuki, Takahiro https://orcid.org/0000-0002-0591-3445
Nakatsuka, Hideki
Sasakawa, Tomoki
Iwasaki, Hajime
Kotake, Yoshifumi
Nagata, Etsuro
Kanmura, Yuichi
- License Information
-
More Information
Article History
Received: 31 May 2021
Accepted: 14 October 2021
First Online: 19 October 2021
Declarations
:
: Takagi S. and Iwasaki H. received speaker’s fees from MSD, distributor of rocuronium in Japan, and Nihon Kohden Corp., manufacturer of the AF-201P™ module and distributor of the TOF Watch SX™ in Japan. Suzuki T. received a speaker’s fee from MSD. Nakatsuka H. received speaker’s fees from MSD, Nihon Kohden Corp., and Maruishi Pharmaceutical, distributor of rocuronium in Japan, and an unrestricted research fund from Nihon Kohden Corp. Kotake Y. received speaker’s fees from MSD, Nihon Kohden Corp., and GE Healthcare Japan, and received an unrestricted research fund from Nihon Kohden Corp. The other authors declare no competing interests.
: Written, informed consent was obtained from all of the patients or their families.
: Patients signed informed consent forms regarding the publication of their data.
